Publication | Closed Access

Alzheimer's disease is not associated with altered concentrations of the nitric oxide synthase inhibitor asymmetric dimethylarginine in cerebrospinal fluid

Alzheimer's DiseaseMedicineDementiaCerebrospinal FluidVascular DementiaNeuropharmacologyNeurochemical BiomarkersNeurologyNeuroscienceNeurodegenerationCerebral Blood FlowBrain PathologyPharmacologyAltered Concentrations